2014
DOI: 10.1016/s1569-1993(14)60180-6
|View full text |Cite
|
Sign up to set email alerts
|

43 Experience with fosfomycin: clinical outcomes at an adult UK CF centre

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1
1

Citation Types

1
1
0

Year Published

2018
2018
2018
2018

Publication Types

Select...
1

Relationship

0
1

Authors

Journals

citations
Cited by 1 publication
(2 citation statements)
references
References 0 publications
1
1
0
Order By: Relevance
“…In previous studies, fosfomycin has been shown to have a good safety profile without significant hepatic or renal impairment [15,18,20]. Our data show a statistically significant rise in the renal function, which however normalises at the end of treatment.…”
Section: Discussionsupporting
confidence: 57%
See 1 more Smart Citation
“…In previous studies, fosfomycin has been shown to have a good safety profile without significant hepatic or renal impairment [15,18,20]. Our data show a statistically significant rise in the renal function, which however normalises at the end of treatment.…”
Section: Discussionsupporting
confidence: 57%
“…Overall, the median duration of IV antibiotic treatment was 17 (20) days, and of IV fosfomycin was 11 (6) days.…”
Section: Coursesmentioning
confidence: 99%